CR20230218A - Nuevos derivados de indazol acetileno - Google Patents

Nuevos derivados de indazol acetileno

Info

Publication number
CR20230218A
CR20230218A CR20230218A CR20230218A CR20230218A CR 20230218 A CR20230218 A CR 20230218A CR 20230218 A CR20230218 A CR 20230218A CR 20230218 A CR20230218 A CR 20230218A CR 20230218 A CR20230218 A CR 20230218A
Authority
CR
Costa Rica
Prior art keywords
sup
acetylene derivatives
new indazole
indazole
new
Prior art date
Application number
CR20230218A
Other languages
English (en)
Spanish (es)
Inventor
Ulrike Obst-Sander
Antonio Ricci
Annick Goergler
David Stephen Hewings
Cosimo Dolente
Georg Jaeschke
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CR20230218A publication Critical patent/CR20230218A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CR20230218A 2020-12-01 2021-11-29 Nuevos derivados de indazol acetileno CR20230218A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20210859 2020-12-01
PCT/EP2021/083279 WO2022117477A1 (en) 2020-12-01 2021-11-29 New indazole acetylene derivatives

Publications (1)

Publication Number Publication Date
CR20230218A true CR20230218A (es) 2023-07-07

Family

ID=73654642

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20230218A CR20230218A (es) 2020-12-01 2021-11-29 Nuevos derivados de indazol acetileno

Country Status (15)

Country Link
US (1) US20240002390A1 (enExample)
EP (1) EP4255908A1 (enExample)
JP (1) JP7840327B2 (enExample)
KR (1) KR20230116799A (enExample)
CN (1) CN116490182A (enExample)
AR (1) AR124170A1 (enExample)
AU (1) AU2021393722A1 (enExample)
CA (1) CA3197659A1 (enExample)
CL (1) CL2023001440A1 (enExample)
CO (1) CO2023006912A2 (enExample)
CR (1) CR20230218A (enExample)
IL (1) IL303064A (enExample)
MX (1) MX2023006176A (enExample)
PE (1) PE20240099A1 (enExample)
WO (1) WO2022117477A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL288522B2 (en) 2019-06-21 2025-02-01 Hoffmann La Roche EGFR inhibitor for cancer treatment
EP4255907A1 (en) 2020-12-01 2023-10-11 F. Hoffmann-La Roche AG New indazole derivatives
US20260007678A1 (en) * 2022-05-13 2026-01-08 Hoffmann-La Roche Inc. Combination of allosteric and orthosteric egfr inhibitors for the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6845165B2 (ja) * 2015-06-30 2021-03-17 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド Ｅｇｆｒ阻害剤およびその使用方法
TW201834651A (zh) * 2016-12-22 2018-10-01 瑞士商赫孚孟拉羅股份公司 化合物
WO2018220149A1 (en) * 2017-06-02 2018-12-06 F. Hoffmann-La Roche Ag Compounds
PE20211388A1 (es) * 2018-06-29 2021-07-27 Hoffmann La Roche Compuestos
MA56507A (fr) * 2019-06-21 2022-04-27 Hoffmann La Roche Nouveaux inhibiteurs d'egfr

Also Published As

Publication number Publication date
CN116490182A (zh) 2023-07-25
JP7840327B2 (ja) 2026-04-03
AU2021393722A1 (en) 2023-04-13
WO2022117477A1 (en) 2022-06-09
PE20240099A1 (es) 2024-01-18
US20240002390A1 (en) 2024-01-04
TW202237611A (zh) 2022-10-01
EP4255908A1 (en) 2023-10-11
CL2023001440A1 (es) 2023-12-01
AR124170A1 (es) 2023-02-22
CO2023006912A2 (es) 2023-06-09
KR20230116799A (ko) 2023-08-04
JP2023550902A (ja) 2023-12-06
CA3197659A1 (en) 2022-06-09
MX2023006176A (es) 2023-06-08
IL303064A (en) 2023-07-01

Similar Documents

Publication Publication Date Title
ZA202206923B (en) New methylquinazolinone derivatives
MX2023001379A (es) Derivados de piperidin-1-il-n-piridina-3-il-2-oxoacet amida utiles para el tratamiento de canceres deficientes en mtap y/o que acumulan mt a.
EP4400502A3 (en) Triazine derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same
EP4523692A3 (en) Modulators of thr-ss and methods of use thereof
SA521422143B1 (ar) 15-pgdh مثبط
MX2022004450A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1.
PH12021551256A1 (en) Pantetheine derivatives and uses thereof
CR20230218A (es) Nuevos derivados de indazol acetileno
MX2022006470A (es) Tiromimeticos novedosos.
MX2022015886A (es) Derivados de amidopirimidona.
MX2023010125A (es) Inhibidores del sarcomero cardiaco.
PH12021552513A1 (en) Pyrrole compounds
CR20210181A (es) Inhibidores de o-glicoproteína-2-acetamido-2-desoxi-3-d-glucopiranosidasa
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
MX2025010256A (es) Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno
MX2024012470A (es) Inhibidores de cinasas dependientes de ciclina 9 (cdk9)
MX2025002166A (es) Compuestos y metodos para modular her2
PH12021552953A1 (en) Tricyclic compounds
CR20200619A (es) Compuestos de cianotriazol y usos de los mismos
MX2023001725A (es) Derivados de espiropiperidinilo sustituidos con heteroarilo y usos farmaceuticos de los mismos.
MX2023009954A (es) Compuestos de aminopirimidina y métodos de uso de estos.
MX2024002674A (es) Derivados de tiadiazolona utiles como activadores de ampk.
MX2024005066A (es) Compuestos de cd73.
JOP20220082A1 (ar) مشتقات 2- آزا سبيرو [3.4] أوكتان كناهضات لـ m4
JOP20220084A1 (ar) مشتقات 5-أوكسا- 2- آزا سبيرو [3.4] أوكتان كناهضات لـ m4